Dialysis showdown: which type helps kidney patients live longer?

NCT ID NCT01413074

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared survival in people with end-stage kidney disease who were randomly assigned to either peritoneal dialysis or hemodialysis. The goal was to see which type of dialysis leads to longer life and fewer complications. The study was conducted in China and was terminated early, so results are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Peritoneal dialysis and hemodialysis
What this could lead to
If successful, this could help doctors choose the best dialysis type for patients with kidney failure.
What could go wrong
The study was terminated early, so results may be incomplete. It only included patients in China, so findings may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hangzhou Hospital of Tranditional Chinese Medicine

    Hangzhou, Zhejiang, 310007, China

  • Huashan Hospital ,Fudan University

    Shanghai, Shanghai Municipality, 200040, China

  • Renji Hospital , Shanghai Jiaotong University , School of Medicine

    Shanghai, Shanghai Municipality, China

  • Ruijin Hospital,Shanghai Jiaotong University , School of Medicine

    Shanghai, Shanghai Municipality, 200025, China

  • Shanghai Changzheng Hospital

    Shanghai, Shanghai Municipality, 200003, China

  • The First Affiliated Hospital , Sun Yet-Sen University

    Guangzhou, Guangdong, 510080, China

  • The First Affiliated Hospital , Zhejiang University, School of Medicine

    Hangzhou, Zhejiang, 310003, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.